This inventor holds 11 USPTO granted patents and 1 published patent application. Top assignee: Biocardia, Inc.. Active years: 2002-2016.
Location History:
- South San Francisco, CA (US) (2002 - 2011)
- San Francisco, CA (US) (2008 - 2015)
- San Carlos, CA (US) (2015)
- Santa Fe, NM (US) (2013 - 2016)
Company Filing History:
Years Active: 2002-2016
Title: Simon H Stertzer: Innovator in Cardiac Treatment
Introduction
Simon H Stertzer is a prominent inventor based in Santa Fe, NM (US), known for his significant contributions to the field of cardiac treatment. With a total of 11 patents to his name, he has made remarkable advancements in medical technology, particularly in the treatment of chronic myocardial infarction.
Latest Patents
One of his latest patents involves a method for treating chronic post-myocardial infarction. This innovative approach utilizes helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in patients who have experienced chronic myocardial infarction. The treatment has been shown to be safe and effective, improving ejection fraction (EF) in patients.
Career Highlights
Simon H Stertzer has established himself as a key figure in the medical field through his work at Biocardia, Inc. His dedication to improving patient outcomes through innovative treatments has garnered attention and respect within the medical community.
Collaborations
Throughout his career, Simon has collaborated with notable professionals, including Peter A Altman and Daniel C Rosenman. These partnerships have contributed to the development of groundbreaking medical solutions.
Conclusion
In summary, Simon H Stertzer is a distinguished inventor whose work in cardiac treatment has the potential to transform patient care. His innovative methods and dedication to research continue to pave the way for advancements in medical technology.